Clinical Trial Update: Parkinson's Disease Patient Study On Absorption, Distribution, Metabolism And Excretion Of Ropinirole [Phase 2]

View source ↗

Summary

Phase 2 pharmacokinetic study update examining absorption, distribution, metabolism and excretion of ropinirole in patients with Parkinson disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• Ropinirole (Requip) (ropinirole)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Parkinson Disease | Phase 2 | Status: COMPLETED